- CH₣36.26bn
- CH₣37.78bn
- CH₣6.72bn
- 67
- 11
- 83
- 53
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,207 | 4,508 | 5,409 | 6,223 | 6,717 |
Cost of Revenue | |||||
Gross Profit | 1,778 | 1,863 | 2,110 | 2,438 | 2,406 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,382 | 3,607 | 4,558 | 4,682 | 5,837 |
Operating Profit | 825 | 901 | 851 | 1,541 | 880 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 719 | 803 | 760 | 1,448 | 790 |
Provision for Income Taxes | |||||
Net Income After Taxes | 648 | 732 | 677 | 1,218 | 655 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 645 | 869 | 2,944 | 1,215 | 654 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 645 | 869 | 2,944 | 1,215 | 654 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 9.78 | 10.6 | 12.4 | 14.6 | 14.4 |
Dividends per Share |